← Back
$CRSP All transactions

CRISPR Therapeutics AG

M

$ Value

Shares

10,000

Price

Filed

May 30

Insider

Name

Patel Naimish

Title

Chief Medical Officer

CIK

0002021679

Roles

Officer

Transaction Details

Transaction Date

2025-05-28

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,000

Footnotes

Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. | Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. | This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028.

Filing Info

Accession No.

0000950170-25-079822

Form Type

4

Issuer CIK

0001674416

Patel Naimish's History

Date Ticker Type Value
2026-03-20 CRSP A $0
2026-03-20 CRSP A $0
2025-10-03 CRSP A $0
2025-05-30 CRSP A $0
2025-05-29 CRSP $141K
2025-05-28 CRSP M
2025-05-28 CRSP M

Other Insiders at CRSP (90d)

Insider Bought Sold Last
Kulkarni Samarth
Chief Executive Officer
$469K 2026-03-23
KASINGER JAMES R.
General Counsel and Secretary
$149K 2026-03-23
Prasad Raju
Chief Financial Officer
$173K 2026-03-23
Patel Naimish
Chief Medical Officer
2026-03-20